Factorial design analysis and optimisation of alginate-Ca-chitosan microspheres

Journal of Microencapsulation

Volumn 30, Issue 1, 2013, Pages 81-92

  Makraduli, Liljana ^a   Crcarevska, Maja Simonoska ^a   Geskovski, Nikola ^a   Dodov, Marija Glavas ^a   Goracinova, Katerina ^a  

^a SS Cyril and Methodius University Faculty of Pharmacy   (Macedonia)

Author keywords

Central composite design; Chitosan Ca alginate; Factorial design; GIT inflammation targeting; Microparticles; Spray drying

Indexed keywords

BUDESONIDE; CALCIUM ALGINATE; CHITOSAN; MICROSPHERE;

ARTICLE; DISSOLUTION; FACTORIAL DESIGN; PARTICLE SIZE; PH; POROSITY; PROCESS OPTIMIZATION; SUSTAINED DRUG RELEASE;

ALGINATES; CALCIUM; CHITOSAN; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEN-ION CONCENTRATION; MICROSPHERES; PARTICLE SIZE; SOLUBILITY;

EID: 84871411992     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2012.700957     Document Type: Article

References (33)

1. Ashford M, Fell JT, Attwood D, Sharma H, Woodhead PJ. An in vivo investigation into the suitability of pH dependent polymers for colonic targeting. Int J Pharm, 1993;95(1-3):193-9.
2. 2+ ions. React Funct Polym, 2004;59(2):129-40.
3. Bandi N, Wei W, Roberts CB, Kotra LP, Kompella UB. Preparation of bude-sonide-and indomethacin-hydroxypropyl-β-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process. Eur J Pharm Sci, 2004;23(2):159-68.
4. Borges O, Borchard G, Verhoef JC, De Sousa A, Junginger HE. Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int J Pharm, 2005;299(1-2):155-66.
5. Coppi G, Iannuccelli V, Bernabei MT, Cameroni R. Alginate microparticles for enzyme peroral administration. Int J Pharm, 2002;242(1-2):263-6.
6. Coppi G, Iannuccelli V, Leo E, Bernabei MT, Cameroni R. Chitosan-alginate microparticles as a protein carrier. Drug Dev Ind Pharm, 2001;27(5):393-400.
7. Council of Europe. 2010. European pharmacopoeia. 7th edn. Strasbourg, France: Council of Europe.
8. De Jaeghere F, Allemann E, Cerny R, Galli B, Steulet AF, Muller I, Schutz H, Doelker E, Gurny R. pH-Dependent dissolving nano-and microparticles for improved peroral delivery of a highly lipophilic compound in dogs. AAPS PharmSci, 2001;3(1):E8.
9. de Mello VA, Ricci-Junior E. Encapsulation of naproxen in nanostructured system: Structural characterization and in vitro release studies. Quim Nova, 2011;34:933-9.
10. Dubey RR, Parikh RH. Studies of PLGA microspheres. Pharm Technol Eur, 2004;16(5):23-34.
11. Glavas Dodov M, Calis S, Crcarevska MS, Geskovski N, Petrovska V, Goracinova K. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: Development and in vitro characterization. Int J Pharm, 2009;381(2):166-75.
12. González-Rodŕiguez ML, Holgado MA, Sánchez-Lafuente C, Rabasco AM, Fini A. Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm, 2002;232(1-2):225-34.
13. Goracinova K. Formulation and preparation of spray-dried alginate-Ca microparticles. Patent no. MP/MK/05/01/FF/BE/01/IP, 2005.
14. Goracinova K, Glavas-Dodov M, Simonoska-Crcarevska M, Geskovski N. 2012. Drug targeting in IBD treatment-Existing and new approaches. In: Karoui S, ed. Inflammatory bowel disease-Advances in pathogenesis and management. In Tech Europe, Rijeka, Croatia, pp. 301-32, ISBN: 978-953-307-891-5.
15. Gottlieb N, Schwartzbach C. 2004. Development of an internal mixing two-fluid nozzle by systematic variation of internal parts. 19th Annual Meeting of ILASS (Europe) Conference Proceedings, Nottingham, UK, p. 97.
16. Korsmeyer RW, Gurny R, Doelker E. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm, 1983;15(1):25-35.
17. Lamprecht A, Schäfer U, Lehr CM. Size-dependent bioadhesion of micro-and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res, 2001a;18(6):788-93.
18. Lamprecht A, Ubrich N, Yamamoto H, Schäfer U, Takeuchi H, Maincent P, Kawashima Y, Lehr CM. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther, 2001b;299(2):775-81.
19. Martinac A, Filipovic-Grcic J, Perissutti B, Voinovich D, Pavelic Z. Spray-dried chitosan/ethylcellulose microspheres for nasal drug delivery: Swelling study and evaluation of in vitro drug release properties. J Microencapsul, 2005;22(5):549-61.
20. Myers HR, Montgomery CD. 2002. Response surface methodology: Process and product optimization using designed experiments. New York: Wiley & Sons.
21. Nakase H, Okazaki K, Tabata Y, Uose S, Ohana M, Uchida K, Nishi T, Debreceni AS, Itoh T, Kawanami C, et al. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trini-trobenzene sulfonic acid-induced colitis. J Pharmacol Exp Ther, 2001;297(3):1122-8.
22. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 1985;60(4):110-11.
23. Peppas NA, Sahlin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm, 1989;57(2):169-72.
24. 3 factorial design. AAPS PharmSciTech, 2003;4(4):565-73.
25. Ritger PL, Peppas NA. A simple equation for desciption of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release, 1987;5(1):23-36.
26. Rodŕiguez M, Vila-Jato JL, Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release, 1998;55(1):67-77.
27. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physicochemical characterization. Eur J Pharm Biopharm, 2007;65(2):215-32.
28. Simonoska Crcarevska M, Glavas Dodov M, Goracinova K. Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa. Eur J Pharm Biopharm, 2008;68(3):565-78.
29. Sutherland IW, 1991. Alginates. In: Byrom D, ed. Biomaterials, novel materials from biological sources. New York: Stockton, pp. 309-31.
30. Tabata Y, Inoue Y, Ikada Y. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable micro-spheres. Vaccine, 1996;14(17-18):1677-85.
31. Tajber L, Corrigan DO, Corrigan OI, Healy AM. Spray drying of budesonide, formoterol fumarate and their composites\I. Physicochemical characterisation. Int J Pharm, 2009;367(1-2):79-85.
32. Toti US, Aminabhavi TM. Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride. J Control Release, 2004;95(3):567-77.
33. Wong SM, Kellaway IW, Murdan S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int J Pharm, 2006;317(1):61-8.